Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 946-342-2 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 8 February 2016 - 4 May 2016
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Justification for type of information:
- In the absence of existing reliable data, the Murine Local Lymph Node Assay (LLNA) was the endorsed method of to assess skin sensitisation potential under REACH, as no EU-OECD in vitro tests for skin sensitisation had been validated. However, the REACH Annex VII information requirements were revised in 2016 to endorse a battery of in vitro assays for skin sensitisation. The LLNA for skin sensitisation (OECD 429) was initiated and completed for the test item prior to changes in regulatory guidance. The reliable and GLP compliant in vivo LLNA was considered sufficient to fulfil the endpoint as the key study.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 016
- Report date:
- 2016
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Version / remarks:
- 2010
- Deviations:
- yes
- Remarks:
- Relative humidity was at times outside protocol range and Day 4 observations of Set 1 animal were not recorded. The deviations were not considered to affect the outcome of the study.
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.2600 (Skin Sensitisation)
- Version / remarks:
- 2003
- Deviations:
- yes
- Remarks:
- Relative humidity was at times outside protocol range and Day 4 observations of Set 1 animal were not recorded. The deviations were not considered to affect the outcome of the study.
- GLP compliance:
- yes
- Type of study:
- mouse local lymph node assay (LLNA)
Test material
- Reference substance name:
- Methyl 2-[[(Z)-(2,4-dimethylcyclohex-3-en-1-ylidene)methyl]amino]benzoate
- Molecular formula:
- C17H21NO2
- IUPAC Name:
- Methyl 2-[[(Z)-(2,4-dimethylcyclohex-3-en-1-ylidene)methyl]amino]benzoate
- Reference substance name:
- Methyl 2-[[(E)-(2,4-dimethylcyclohex-3-en-1-ylidene)methyl]amino]benzoate
- Molecular formula:
- C17H21NO2
- IUPAC Name:
- Methyl 2-[[(E)-(2,4-dimethylcyclohex-3-en-1-ylidene)methyl]amino]benzoate
Constituent 1
Constituent 2
In vivo test system
Test animals
- Species:
- mouse
- Strain:
- other: CBA/JcrHSD
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Females nulliparous and non-pregnant: Yes
- Weight at study initiation: 18.3 to 24.2 g
- Housing: 1 to 5 per cage in polycarbonate box with bedding
- Diet:, PMI Feeds Inc. Formulab #5008, ad libitum
- Water: Municipal water supply, ad libitum
- Acclimation period: At least 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20-23°C
- Humidity (%): 31-94%
- Air changes (per hr): 10+
- Photoperiod (hrs dark / hrs light): 12-hour light/dark cycle
- IN-LIFE DATES: From: 25 December 2015 and 26 February 2016 To: 07 March 2016 and 02 May 2016
Study design: in vivo (LLNA)
- Vehicle:
- acetone/olive oil (4:1 v/v)
- Concentration:
- Vehicle control, 2.5, 5, 10, 25 and 50% test item in vehicle, and 100% test item
- No. of animals per dose:
- 5
- Details on study design:
- PRE-SCREEN TESTS: A range finding test was not conducted.
MAIN STUDY: The study was conducted in two sets, each consisting of a vehicle control and positive control. Test item concentrations 25, 50 and 100% were tested in Set 1 and test item concentrations of 2.5, 5 and 10% were tested in Set 2.
ANIMAL ASSIGNMENT AND TREATMENT: five animals per test item group
- Name of test method: Determination of disintegrations per minute (DPM) by liquid scintillation counting
- Criteria used to consider a positive response: ECETOC Potency Classification: Weak (10% ≤ EC3 ≤ 100%), moderate (1% ≤ EC3 < 10%), strong (0.1% ≤ EC3 < 1%), extreme (EC3 < 0.1%)
TREATMENT PREPARATION AND ADMINISTRATION: On Days 1, 2 and 3, each test animal received an open application of 25 µL of the treatment solution to the dorsum of both ears. Animals were given a two-day rest period on Days 4 and 5. On Day 6, animals were injected in the tail vein with tritiated methyl-thymidine and sacrificed 5 hours after injection by CO2 overdose.
Individual body weights were recorded on Day 1 prior to dosing and on Day 6 prior to injection. Animals were observed daily for clinical signs of toxicity and any excessive test site irritation. - Positive control substance(s):
- hexyl cinnamic aldehyde (CAS No 101-86-0)
- Statistics:
- A one-way parametric analysis of variance (ANOVA) with Dunnett's Multiple Comparisons Test was performed on DPM counts at a significance level of p<0.01. The EC3 (estimated concentration required for a 3-fold SI value) were then calculated.
Results and discussion
- Positive control results:
- SI = 11.8 and 4.9
In vivo (LLNA)
Resultsopen allclose all
- Key result
- Parameter:
- EC3
- Value:
- 9.5
- Parameter:
- SI
- Value:
- < 3
- Test group / Remarks:
- 2.5 and 5% test item concentration
- Parameter:
- SI
- Value:
- >= 3
- Test group / Remarks:
- 10, 25, 50 and 100% test item concentration
- Cellular proliferation data / Observations:
- DETAILS ON STIMULATION INDEX CALCULATION
Test item / vehicle control
EC3 CALCULATION
EC3 = c+[(3-d/(b-d)] x (a-c), using SI values closest to 3, one above and one below, where:
a = the dose concentration with higher SI
b = the higher SI value
c = the dose concentration with lower SI
d = the lower SI value
CLINICAL OBSERVATIONS: One mortality was observed in the positive control (Set I) and 100% test item concentration. No clinical signs were observed in animals in Set 1. All animals in Set 2 had matted fur around the ears.
BODY WEIGHTS: All survivors in Set 1 gained weight normally. In Set 2, one animal in the positive control, one animal treated with 2.5% test item concentration and three animals treated with 10% test item concentration lost weight during the study.
Any other information on results incl. tables
Table 1. LLNA results
Test item concentration (%) | Average count per mouse (DPM) | Number of mice in group | Test/Vehicle Control Ratio |
Set 1 | |||
Vehicle control | 1911 | 5 | NA |
25 | 15948 | 5 | 8.4 |
50 | 15378 | 5 | 8.0 |
100 | 12846 | 4 | 6.7 |
Positive control | 22454 | 4 | 11.8 |
Set 2 | |||
Vehicle control | 1684 | 5 | NA |
2.5 | 3615 | 5 | 2.2 |
5 | 3645 | 5 | 2.2 |
10 | 5224 | 5 | 3.1 |
Positive control | 8320 | 5 | 4.9 |
NA: Not Applicable
Applicant's summary and conclusion
- Interpretation of results:
- Category 1B (indication of skin sensitising potential) based on GHS criteria
- Conclusions:
- The test tem produced a stimulation index ≥ 3 at all test item concentrations except 2.5 and 5%. The EC3 value was calculated to be 9.5%.
- Executive summary:
The skin sensitisation potential of the test item was determined in a local lymph node assay (LLNA) in female CBA/JcrHSD mice (Murphy 2016). Doses of 2.5, 5, 10, 25, 50 and 100% test item was applied to the dorsum of both ears on Days 1, 2 and 3, alongside a vehicle control (4:1 v/v acetone:oilve oil) and positive control. All animals were given a two-day rest period on Days 4 and 5 and animals were injected with tritiated methyl-thymidine and sacrificed on Day 6. The test item produced a stimulation index ≥ 3 at all test item concentrations except 2.5 and 5%. The EC3 value was calculated to be 9.5%.
The LLNA (EU B.42; OECD 429) is an intentionally accepted in vivo test method to detect skin sensitisation (Category 1, 1A or 1B under CLP) and/or absence of effects requiring classification for skin sensitisation (i.e. not classified under CLP), as described in the Annex to the EU Test Methods (TM) Regulation (Council Regulation (EC) No 440/2008). Conducted according to the aforementioned guidelines and GLP, the LLNA passed all validity criteria and was considered to be reliable without restriction (Klimisch 1).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.